dc.contributor.author | Cui, Guanglin | |
dc.contributor.author | Florholmen, Jon | |
dc.contributor.author | Goll, Rasmus | |
dc.date.accessioned | 2022-11-03T18:58:54Z | |
dc.date.available | 2022-11-03T18:58:54Z | |
dc.date.created | 2022-08-09T12:40:46Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Cui, G., Florholmen, J. & Goll, R. (2022). Could mucosal TNF transcript as a biomarker candidate help optimize anti-TNF biological therapy in patients with ulcerative colitis? Frontiers in Immunology, 13: 11, 881112. doi: | en_US |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://hdl.handle.net/11250/3030025 | |
dc.language.iso | eng | en_US |
dc.publisher | Frontiers | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis? | en_US |
dc.title.alternative | Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis? | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2022 The Authors | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologi: 773 | en_US |
dc.source.pagenumber | 11 | en_US |
dc.source.volume | 13 | en_US |
dc.source.journal | Frontiers in Immunology | en_US |
dc.identifier.doi | 10.3389/fimmu.2022.881112 | |
dc.identifier.cristin | 2041944 | |
dc.source.articlenumber | 881112 | en_US |